VanEck Associates’s Advent Technologies ADN Stock Holding History
Bought
Maintained
Sold
Other funds holding ADN
HF
VF
VanEck Associates's ADN Position: Q2 2023 in Review
VanEck Associates sold out of Advent Technologies (ADN) in Q2 2023, closing a stake of 6,791 shares — an estimated $216K sold.
VanEck Associates first reported a position in ADN in Q2 2021 and held it in 7 quarters. The position peaked at $590K in Q4 2021. 34 funds tracked by Wall St. Rank hold ADN as of Q2 2023.
- VanEck Associates reported no remaining Advent Technologies position as of Q2 2023 after selling out during the quarter.
- VanEck Associates sold 6,791 Advent Technologies shares in Q2 2023, an estimated $216K.
- VanEck Associates first reported a position in Advent Technologies in Q2 2021 and held it in 7 quarters.
- VanEck Associates's Advent Technologies position peaked at $590K in Q4 2021.
- 34 funds tracked by Wall St. Rank held Advent Technologies as of Q2 2023.
Based on VanEck Associates's 13F filing for Q2 2023, filed 3 Aug 2023.